A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants
a study on COVID-19
Participants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19 at Different Stages of the Protocol Prevention Vaccine Disease Progression Ad26.COV2.S
- accepting new patients
- Start Date
- Completion Date
- Janssen Vaccines & Prevention B.V.
- To learn how to participate in this trial please click here.
- Phase 3
- Study Type
- Last Updated